DarshanTalks Podcast

392 Episodes

1. Getting Ready for SOS 2025: FDA 483s, SOPs, and Site Survival

   Published: 3/10/2025
2. Maximizing Site Value

   Published: 3/7/2025
3. 5 Key Areas to Review in Clinical Trial Agreements

   Published: 3/5/2025
4. Discussing Stem Cell Research Opportunities with a Research Site Owner

   Published: 3/3/2025
5. Quality Management: A Must in Clinical Trial Contracts

   Published: 3/1/2025
6. AI-Powered Chatbots in Pharma Sales and Education

   Published: 2/27/2025
7. Will New Tariffs Disrupt Your Next Pharma Deal?

   Published: 2/26/2025
8. Protecting Patient Data in a Changing Regulatory Landscape

   Published: 2/25/2025
9. Off-Label Promotion Changes in 2025

   Published: 2/24/2025
10. Turning Physicians into Leaders

    Published: 2/21/2025
11. Key Regulatory Agencies in Pharma M&A

    Published: 2/20/2025
12. Does E6 (R3) Blur the Line Between GCP and Privacy Laws?

    Published: 2/19/2025
13. RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy

    Published: 2/18/2025
14. America’s Research Future in Jeopardy

    Published: 2/15/2025
15. Trump Administration’s NIH cuts: Will they cripple US medical research?

    Published: 2/14/2025
16. DEI Under Trump: What It Means for Clinical Trials

    Published: 2/13/2025
17. CAPA & RCA: A Must for Pharma M&A

    Published: 2/12/2025
18. Trump Targets Indirect Costs in NIH Funding

    Published: 2/11/2025
19. The USAID Halt and Its Consequences for Clinical Research

    Published: 2/10/2025
20. Ebola Vaccine Trial in Record Time!

    Published: 2/8/2025